Scope of worldwide hepatitis C problem

Robert S. Brown, Paul J. Gaglio

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

Key Points: 1. Hepatitis C is a global health problem affecting over 170 million people worldwide. 2. There is wide geographic variation in both prevalence and genotype distribution of hepatitis C virus on a global level. 3. Most hepatitis C virus is spread parenterally, either through intravenous drug use or, in lesser-developed countries, through blood contamination during medical procedures. 4. Hepatitis C is a leading cause of end-stage liver disease and hepatocellular carcinoma. 5. Despite a declining incidence of new infections, the burden of disease, both in terms of mortality and in terms of cost, is expected to increase over the next decade.

Original languageEnglish (US)
JournalLiver Transplantation
Volume9
Issue number11
DOIs
StatePublished - Nov 2003
Externally publishedYes

Fingerprint

Hepatitis C
Hepacivirus
End Stage Liver Disease
Developed Countries
Hepatocellular Carcinoma
Genotype
Costs and Cost Analysis
Mortality
Incidence
Infection
Pharmaceutical Preparations
Global Health

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Scope of worldwide hepatitis C problem. / Brown, Robert S.; Gaglio, Paul J.

In: Liver Transplantation, Vol. 9, No. 11, 11.2003.

Research output: Contribution to journalArticle

Brown, Robert S. ; Gaglio, Paul J. / Scope of worldwide hepatitis C problem. In: Liver Transplantation. 2003 ; Vol. 9, No. 11.
@article{3d2396ae443342de97ca8dc9c30bef7c,
title = "Scope of worldwide hepatitis C problem",
abstract = "Key Points: 1. Hepatitis C is a global health problem affecting over 170 million people worldwide. 2. There is wide geographic variation in both prevalence and genotype distribution of hepatitis C virus on a global level. 3. Most hepatitis C virus is spread parenterally, either through intravenous drug use or, in lesser-developed countries, through blood contamination during medical procedures. 4. Hepatitis C is a leading cause of end-stage liver disease and hepatocellular carcinoma. 5. Despite a declining incidence of new infections, the burden of disease, both in terms of mortality and in terms of cost, is expected to increase over the next decade.",
author = "Brown, {Robert S.} and Gaglio, {Paul J.}",
year = "2003",
month = "11",
doi = "10.1053/jlts.2003.50244",
language = "English (US)",
volume = "9",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

TY - JOUR

T1 - Scope of worldwide hepatitis C problem

AU - Brown, Robert S.

AU - Gaglio, Paul J.

PY - 2003/11

Y1 - 2003/11

N2 - Key Points: 1. Hepatitis C is a global health problem affecting over 170 million people worldwide. 2. There is wide geographic variation in both prevalence and genotype distribution of hepatitis C virus on a global level. 3. Most hepatitis C virus is spread parenterally, either through intravenous drug use or, in lesser-developed countries, through blood contamination during medical procedures. 4. Hepatitis C is a leading cause of end-stage liver disease and hepatocellular carcinoma. 5. Despite a declining incidence of new infections, the burden of disease, both in terms of mortality and in terms of cost, is expected to increase over the next decade.

AB - Key Points: 1. Hepatitis C is a global health problem affecting over 170 million people worldwide. 2. There is wide geographic variation in both prevalence and genotype distribution of hepatitis C virus on a global level. 3. Most hepatitis C virus is spread parenterally, either through intravenous drug use or, in lesser-developed countries, through blood contamination during medical procedures. 4. Hepatitis C is a leading cause of end-stage liver disease and hepatocellular carcinoma. 5. Despite a declining incidence of new infections, the burden of disease, both in terms of mortality and in terms of cost, is expected to increase over the next decade.

UR - http://www.scopus.com/inward/record.url?scp=0242456086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242456086&partnerID=8YFLogxK

U2 - 10.1053/jlts.2003.50244

DO - 10.1053/jlts.2003.50244

M3 - Article

VL - 9

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 11

ER -